Edoxaban versus warfarin in patients with atrial fibrillation.
- R. Giugliano, C. Ruff, E. Antman
- MedicineNew England Journal of Medicine
- 27 November 2013
Both once-daily regimens of edoxaban were noninferior to warfarin with respect to the prevention of stroke or systemic embolism and were associated with significantly lower rates of bleeding and death from cardiovascular causes.
A comparison of rate control and rhythm control in patients with atrial fibrillation.
Management of atrial fibrillation with the rhythm-control strategy offers no survival advantage over the rate- control strategy, and there are potential advantages, such as a lower risk of adverse drug effects, with the rate -control strategy.
Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators.
In patients with a prior myocardial infarction who are at high risk for ventricular tachyarrhythmia, prophylactic therapy with an implanted defibrillator leads to improved survival as compared with conventional medical therapy.
Rhythm control versus rate control for atrial fibrillation and heart failure.
- D. Roy, M. Talajic, A. Waldo
- MedicineNew England Journal of Medicine
- 19 June 2008
In patients with atrial fibrillation and congestive heart failure, a routine strategy of rhythm control does not reduce the rate of death from cardiovascular causes, as compared with a rate-control strategy.
Relationships Between Sinus Rhythm, Treatment, and Survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study
- S. Corley, A. Epstein, D. Wyse
- MedicineCirculation
- 30 March 2004
An “on-treatment” analysis of the relationship of survival to cardiac rhythm and treatment as they changed over time suggests that any beneficial antiarrhythmic effects of AADs are offset by their adverse effects.
Pathophysiology and Prevention of Atrial Fibrillation
- M. Allessie, P. Boyden, A. Waldo
- MedicineCirculation
- 6 February 2001
Atrial fibrillation (AF) is a ubiquitous yet diverse cardiac arrhythmia whose incidence increases with age; with most forms of cardiac and some pulmonary diseases; and with a number of metabolic,…
Subclinical atrial fibrillation and the risk of stroke.
- M. Bersohn, A. Waldo, J. Halperin
- MedicineNew England Journal of Medicine
- 5 April 2012
Prevention of Atrial Fibrillation: Report From a National Heart, Lung, and Blood Institute Workshop
- E. Benjamin, Peng-Sheng Chen, D. Wyse
- MedicineCirculation
- 3 February 2009
The panel proposed the following recommendations to enhance understanding of the epidemiology of AF in the population by systematically and longitudinally investigating symptomatic and asymptomatic AF in cohort studies.
2014 AATS guidelines for the prevention and management of perioperative atrial fibrillation and flutter for thoracic surgical procedures.
- G. Frendl, Alissa C Sodickson, D. Adler
- Medicine, BiologyJournal of Thoracic and Cardiovascular Surgery
- 1 September 2014
...
...